Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

NCT04780295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2708

Last updated 2023-01-25

No results posted yet for this study

Summary

This online-based, observational retrospective registry aims to (i) study the rate of cardiovascular events, encompassing venous thromboembolic and arterial events, in consecutive hospitalized patients with coronavirus (Covid19), (ii) investigate the prevalent use of thromboprophylaxis, (iii) describe the use of imaging tests for the detection of cardiovascular events in patients with Covid19. This will also facilitate and constitute the basis for the conduction of interventional thromboprophylaxis studies in patients with Covid19.

Conditions

  • Covid19

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER
  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Stavros Konstantinides, MD, Prof · University Medical Center Mainz, Johannes Gutenberg University Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2021-05-18
Completion
2021-05-18

Countries

  • Brazil
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Mexico
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780295 on ClinicalTrials.gov